This bill would repeal the Trump administration’s harmful travel ban and place checks on future administrations to ensure that such bans aren’t adopted without good reason. It would also ensure that travelers entering the U.S. who are detained & inspected have access to legal counsel & can consult with other interested parties. Finally, this bill would prevent prescription drug companies from engaging in anti-competitive behavior that increases prices for consumers.
This bill would harm national security by undermining the executive branch’s ability to restrict travel to the U.S. from places where there is an outbreak of a highly infectious disease or which lack the capacity to vet travelers for terrorism links. It’s also a deeply cynical political ploy by House Democrats to include prescription drug pricing reforms that could pass as a standalone bill to a package of unrelated measures that are facing a veto threat.